United Guardian (UG) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Powered by 
Analysis
United Guardian (UG) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn | 2.47% |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn | 39.28% |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn | 12.12% |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | -28.09% |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -36.57% |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn | 42.23% |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 8.71% |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | 10.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.52% |
| Mar 31, 2026 | 5.08% |
| Dec 31, 2025 | -4.84% |
| Sep 30, 2025 | 10.24% |
| Jun 30, 2025 | 10.28% |
| Mar 31, 2025 | -14.94% |
| Dec 31, 2024 | -25.67% |
| Sep 30, 2024 | -5.45% |
| Jun 30, 2024 | -12.42% |
| Mar 31, 2024 | -7.81% |
| Dec 31, 2023 | 10.94% |
| Sep 30, 2023 | -4.41% |
| Jun 30, 2023 | -22.96% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -18.83% |
| Sep 30, 2022 | -50.67% |
| Jun 30, 2022 | -22.98% |
| Mar 31, 2022 | -9.33% |
| Dec 31, 2021 | 23.18% |
| Sep 30, 2021 | -10.54% |